Výsledky vyhledávání - "K. MacLennan"

Implementing nitrous oxide cracking technology in the labour ward to reduce occupational exposure and environmental emissions: a quality improvement study

Autor: A. Pinder, L. Fang, A. Fieldhouse, A. Goddard, R. Lovett, J. Khan‐Perez, K. Maclennan, E. Mason, T. MacCarrick, C. Shelton

Publikováno v: AnaesthesiaReferences. 77(11)

Nitrous oxide, a potent greenhouse gas, is a common labour analgesic. One method which may reduce its carbon footprint is to 'crack' the exhaled gas into nitrogen and oxygen using catalytic destruction. In this quality improvement project, based on e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5b2d084a69c1d21b6dea312cd867481
https://pubmed.ncbi.nlm.nih.gov/36108342

Zobrazit plný text záznamu

OA04.03 Feasibility of Prospective Dietetic Assessment and Intervention of Patients Receiving Chemo-Radiotherapy for Lung Cancer

Autor: M. Brown, A. Tufail, Iain Phillips, S. Campbell, T. Evans, C. Barrie, David Finn, F. Little, K. Maclennan, C. Samuelson, Melanie Mackean

Publikováno v: Journal of Thoracic Oncology. 16:S853-S854

Introduction: Chemo-radiotherapy for lung cancer can be a morbid treatment, often in an older and co-morbid population. Our patients are not routinely seen by a dietitian. Methods: As a pilot project, all patients receiving either sequential or concu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6ec9de737a7258712d901e6efc9d7c62
https://doi.org/10.1016/j.jtho.2021.08.046

Zobrazit plný text záznamu

A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY study

Autor: K MacLennan, Ellen Warner, Steven A. Narod, Christine M. Friedenreich, Ivo A. Olivotto, Joanne Stephen, Nancy N. Baxter, May Lynn Quan, D Howell, K Metcalfe, Mohammad R. Akbari

Publikováno v: Curr Oncol
Current Oncology
Volume 27
Issue 5
Pages 6751-523

Introduction: The understanding of the biology and epidemiology of, and the optimal therapeutic strategies for, breast cancer (bca) in younger women is limited. We present the rationale, design, and initial recruitment of Reducing the Burden of Breas

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::065d2782719b5f40146471ae5558df77
https://pubmed.ncbi.nlm.nih.gov/33173392

Zobrazit plný text záznamu

Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer

Autor: M, Stares, T E, Ding, C, Stratton, F, Thomson, M, Baxter, H, Cagney, K, Cumming, A, Swan, F, Ross, C, Barrie, K, Maclennan, S, Campbell, T, Evans, A, Tufail, S, Harrow, H, Lord, B, Laird, M, MacKean, I, Phillips

Publikováno v: Stares, M, Ding, T-E, Stratton, C, Thomson, F, Baxter, M, Cagney, H, Cumming, K, Swan, A, Ross, F, Barrie, C, Maclennan, K, Campbell, S, Evans, T, Tufail, A, Harrow, S, Lord, H, Laird, B J A, Mackean, M J & Phillips, I 2022, ' Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small cell lung cancer ', ESMO Open, vol. 7, no. 2, 100445 . https://doi.org/10.1016/j.esmoop.2022.100445

IntroductionPembrolizumab is an established first-line option for patients with advanced non-small-cell lung cancer (NSCLC) expressing programmed death-ligand 1 ≥50%. Durable responses are seen in a subset of patients; however, many derive little c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f055870768dd8c9243fd1deb2ba3d07
https://doi.org/10.1016/j.esmoop.2022.100445

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání